Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.69 is 63% above its 5-year average of -4.57, near the high end of its 5-year range (-8.37–-1.27).
5.62% below its 12-month average of -1.60.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-06-30): -0.60.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.69
EARNINGS PER SHARE (EPS) AVG TTM
-1.60
EARNINGS PER SHARE (EPS) AVG 3Y
-3.62
EARNINGS PER SHARE (EPS) AVG 5Y
-4.57
EARNINGS PER SHARE (EPS) AVG 10Y
-10.11
EARNINGS PER SHARE (EPS) AVG 15Y
-20.43
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.62%
CURRENT VS 3Y AVG
+53.38%
CURRENT VS 5Y AVG
+63.01%
CURRENT VS 10Y AVG
+83.29%
CURRENT VS 15Y AVG
+91.73%
CURRENT VS 20Y AVG
N/A
Edesa Biotech, Inc.
Market Cap
$35.84M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
Market Cap
$35.84M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
Market Cap
$35.76M
Earnings Per Share (EPS)
-1.96
TTM Avg
-0.82
3Y Avg
-0.31
5Y Avg
-0.18
Market Cap
$35.52M
Earnings Per Share (EPS)
-1.17
TTM Avg
-1.36
3Y Avg
-0.92
5Y Avg
-0.84
Market Cap
$36.21M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$34.97M
Earnings Per Share (EPS)
-13.84
TTM Avg
-117.78
3Y Avg
-126.66
5Y Avg
-275.31
Market Cap
$34.35M
Earnings Per Share (EPS)
0.94
TTM Avg
-0.29
3Y Avg
-1.25
5Y Avg
-1.59
Market Cap
$37.93M
Earnings Per Share (EPS)
N/A
TTM Avg
-21.23
3Y Avg
-13.85
5Y Avg
-9.58
Market Cap
$33.63M
Earnings Per Share (EPS)
-64.88
TTM Avg
-36.48
3Y Avg
-29.14
5Y Avg
-27.68
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $35.84M | -1.69 | -1.60 | -3.62 | -4.57 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | -2.13 | -3.42 | -5.72 | -5.72 |
| DocGo Inc. (DCGO)vs › | $35.76M | -1.96 | -0.82 | -0.31 | -0.18 |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | -1.17 | -1.36 | -0.92 | -0.84 |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | -2.56 | -5.45 | -15.27 | -9.79 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -13.84 | -117.78 | -126.66 | -275.31 |
| Elutia Inc (ELUT)vs › | $34.35M | 0.94 | -0.29 | -1.25 | -1.59 |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | N/A | -21.23 | -13.85 | -9.58 |
| Scilex Holding Company (SCLX)vs › | $33.63M | -64.88 | -36.48 | -29.14 | -27.68 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | -1.26 | -0.80 | -2.79 | -3.86 |
Trailing EPS (TTM)
$-1.69
Forward EPS (Est.)
$-2.07
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | -1.27 |
| 2024-09-30 | -1.93 |
| 2023-09-30 | -2.93 |
| 2022-09-30 | -8.37 |
| 2021-09-30 | -7.73 |
| 2020-09-30 | -5.18 |
| 2019-09-30 | -4.79 |
| 2018-09-30 | -3.32 |
| 2017-09-30 | -36.78 |
| 2016-09-30 | -23.92 |
| 2015-09-30 | -15.01 |
| 2014-08-31 | -46.75 |
| 2013-08-31 | -121.14 |
| 2012-08-31 | -49.86 |
| 2011-08-31 | -78.14 |
| 2010-08-31 | -15.88 |
| 2009-04-30 | -7.67 |
